Home Table of Contents

§ 21-2C-16. Report

West's Annotated Code of MarylandHealth--GeneralEffective: April 11, 2023

West's Annotated Code of Maryland
Health--General
Title 21. Food, Drugs, and Cosmetics (Refs & Annos)
Subtitle 2c. Prescription Drug Affordability Board (Refs & Annos)
Effective: April 11, 2023
MD Code, Health - General, § 21-2C-16
§ 21-2C-16. Report
Currentness
On or before December 1, 2026, the Board, in consultation with the Stakeholder Council, shall report to the Senate Finance Committee and the House Health and Government Operations Committee, in accordance with § 2-1257 of the State Government Article, on:
(1) The legality, obstacles, and benefits of setting upper payment limits on all purchases and payor reimbursements of prescription drug products in the State; and
(2) Recommendations regarding whether the General Assembly should pass legislation to expand the authority of the Board to set upper payment limits to all purchases and payor reimbursements of prescription drug products in the State.

Credits

Added by Acts 2023, c. 39, § 1, eff. April 11, 2023; Acts 2023, c. 40, § 1, eff. April 11, 2023.
MD Code, Health - General, § 21-2C-16, MD HEALTH GEN § 21-2C-16
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document